Metastatic spread of the PAIII prostatic adenocarcinoma after implantation in the tail of the rat
- PMID: 3703746
- DOI: 10.1002/pros.2990080307
Metastatic spread of the PAIII prostatic adenocarcinoma after implantation in the tail of the rat
Abstract
The spontaneous metastatic spread of a suspension of PAIII prostatic adenocarcinoma cells from the tail site of implantation was analyzed over a period of 5 weeks in male Lobund-Wistar (LW) rats. Following subcutaneous injection of the PAIII cells, the tumor metastasized through the primary lymphatic drainage. PAIII microfoci were evident in the gluteal and iliac lymph nodes prior to colonization of the lungs. Growth of the primary tumor was evidenced by significant weight differences of the tails of PAIII-bearing and control rats 1 week after tumor implantation. Time-dependent sequential spread of the adenocarcinoma was quantitated. Significant differences were noted between PAIII-bearing and control animals with respect to the gluteal lymph node weights (+2 weeks), iliac lymph node weights (+3 weeks), dry lung weights, and lung colony numbers (+4 weeks) after tumor implantation. During the course of these studies, the whole blood prothrombin, activated partial thromboplastin, and recalcification times for the PAIII-bearing animals were similar to those of the control group. These findings indicate that there were no gross changes in systemic blood coagulation accompanying the metastasis of PAIII cells from the primary tumor. The tumor in LW rats produced a consistent pattern of growth and metastasis that is suitable for quantitation. The PAIII prostatic adenocarcinoma is a sensitive and reproducible system that may be useful to evaluate potential antimetastatic and cytotoxic agents for the treatment of hormone-insensitive prostatic cancer.
Similar articles
-
Raloxifene (LY156758) produces antimetastatic responses and extends survival in the PAIII rat prostatic adenocarcinoma model.Prostate. 1995 Oct;27(4):220-9. doi: 10.1002/pros.2990270407. Prostate. 1995. PMID: 7479389
-
Inhibition of PAIII rat prostatic adenocarcinoma growth and metastasis by a new diarylsulfonylurea antitumor agent, LY181984.J Urol. 1992 Feb;147(2):500-4. doi: 10.1016/s0022-5347(17)37288-9. J Urol. 1992. PMID: 1732631
-
Inhibitory effect of warfarin on the metastasis of the PAIII prostatic adenocarcinoma in the rat.J Urol. 1986 Jan;135(1):163-6. doi: 10.1016/s0022-5347(17)45554-6. J Urol. 1986. PMID: 3941458
-
[Metastatic lymph node collision of a prostatic adenocarcinoma and an urothelial carcinoma and review of the literature].Ann Pathol. 2015 Dec;35(6):496-501. doi: 10.1016/j.annpat.2015.09.005. Epub 2015 Nov 17. Ann Pathol. 2015. PMID: 26597142 Review. French.
-
Model for mediastinal lymph node metastasis produced by orthotopic intrapulmonary implantation of lung cancer cells in mice.Hum Cell. 1999 Dec;12(4):197-204. Hum Cell. 1999. PMID: 10834106 Review.
Cited by
-
Pharmacological ascorbic acid suppresses syngeneic tumor growth and metastases in hormone-refractory prostate cancer.In Vivo. 2010 May-Jun;24(3):249-55. In Vivo. 2010. PMID: 20554995 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical